URGN
UROGEN PHARMA LT
Health Care·Biotechnology·UNITED STATES
$46.80
MCap $2.3B
as of 2026-08-20
Total
B9w
Fund
C9w
Quant
A9w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-08-20
MIDOS SI
-1.15
Sentiment 91.4%— long zone
−3 oversold0+3 overbought
Signal
BEARISH
Actual
$46.80
Adaptive Mean
$49.64
-2.84 vs mean
Adaptive σ
1.23
MIDOS BB
$47.18 – $52.10
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-08-21
Composite Z
+0.12
ROE
—
Z —
Rev Gr
199.2%
Z +0.98
EPS Gr
—
Z -0.11
OPM Gr
171.3%
Z +0.18
FCF Yld
-4.7%
Z -0.59
EPS Surp
-0.1%
Z -0.06
EPS 3mo Δ
113.3%
Z +0.34
Fwd P/E
16.60
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-08-21
Q3M
19.47
Q6M
13.69
Q12M
8.18
MA 30/100
1.337
Bullish (MA30 > MA100)
α (Jensen)
1.7993
β (12M)
1.14
σ (12M)
0.670
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
71%
Q Percentile
92%
Divergence
-21.5
Tier
TRIM — WATCH
Momentum ahead of fundamentals.
Kirkpatrick RS & Persistence
RS
120.7
RS Pctl
98%
RS Decile
D10
Persistence
9w
at grade B
Options / OI Analysis
as of 2026-05-25
OI Center
$28.90
+0.1% from spot
Max Pain
$26.00
PCR (OI)
0.36
contrarian_bearish
Skew
0.17
OI Composite
-1
neutral
Direction
neutral